FDA Inspection 1238557 — Antonio Passaro, M.D.
The FDA completed an inspection of Antonio Passaro, M.D. on April 12, 2024 in Milan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Milan (Italy)
Additional Details
Clinical Investigator (CI)